{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:23:50Z","timestamp":1773077030184,"version":"3.50.1"},"reference-count":5,"publisher":"American Diabetes Association","issue":"8","license":[{"start":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:00:00Z","timestamp":1563753600000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK094176"],"award-info":[{"award-number":["U01 DK094176"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01 DK094157"],"award-info":[{"award-number":["U01 DK094157"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,8,1]]},"DOI":"10.2337\/dci19-0026","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T00:25:56Z","timestamp":1563841556000},"page":"e137-e137","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":2,"title":["Response to Comment on Braffett et al. Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT\/EDIC Study. Diabetes Care 2019;42:657\u2013664"],"prefix":"10.2337","volume":"42","clinical-trial-number":[{"clinical-trial-number":"nct00360815","registry":"10.18810\/clinical-trials-gov","type":"results"},{"clinical-trial-number":"nct00360893","registry":"10.18810\/clinical-trials-gov","type":"results"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2184-9754","authenticated-orcid":false,"given":"Barbara H.","family":"Braffett","sequence":"first","affiliation":[{"name":"Biostatistics Center, The George Washington University, Rockville, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5318-9677","authenticated-orcid":false,"given":"Samuel","family":"Dagogo-Jack","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, University of Tennessee Health Science Center, Memphis, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4944-7968","authenticated-orcid":false,"given":"Ionut","family":"Bebu","sequence":"additional","affiliation":[{"name":"Biostatistics Center, The George Washington University, Rockville, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William I.","family":"Sivitz","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Iowa, Iowa City, IA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Larkin","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Diabetes Center, Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orville","family":"Kolterman","sequence":"additional","affiliation":[{"name":"University of California, San Diego, La Jolla, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Lachin","sequence":"additional","affiliation":[{"name":"Biostatistics Center, The George Washington University, Rockville, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2019,7,12]]},"reference":[{"key":"2022031300223459700_B1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2337\/dc19-0730","article-title":"Comment on Braffett et al. Association of insulin dose, cardiometabolic risk factors, and cardiovascular disease in type 1 diabetes during 30 years of follow-up in the DCCT\/EDIC study","volume":"42","author":"Snaith","year":"2019","journal-title":"Diabetes Care"},{"key":"2022031300223459700_B2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2337\/db10-0328","article-title":"Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: the CACTI study","volume":"60","author":"Schauer","year":"2011","journal-title":"Diabetes"},{"key":"2022031300223459700_B3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2337\/dc18-1574","article-title":"Association of insulin dose, cardiometabolic risk factors, and cardiovascular disease in type 1 diabetes during 30 years of follow-up in the DCCT\/EDIC study","volume":"42","author":"Braffett","year":"2019","journal-title":"Diabetes Care"},{"key":"2022031300223459700_B4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrm.2017.89","article-title":"Biochemical and cellular properties of insulin receptor signalling","volume":"19","author":"Haeusler","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2022031300223459700_B5","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S2213-8587(17)30194-8","article-title":"Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial","volume":"5","author":"Petrie","year":"2017","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dci19-0026","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/8\/e137\/529450\/dci190026.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/8\/e137\/529450\/dci190026.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T03:35:45Z","timestamp":1647142545000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/42\/8\/e137\/36214\/Response-to-Comment-on-Braffett-et-al-Association"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,12]]},"references-count":5,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,7,12]]},"published-print":{"date-parts":[[2019,8,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dci19-0026","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,12]]}}}